It is known that endoplasmic reticulum (ER) stress in cells and extracellular vesicles (EVs) plays a significant role in cancer cells, therefore the evaluation of compounds that can regulate ER stress and EV secretion would be a suitable system for further screening and development of new drugs. In this study, we evaluated chemical chaperones derived from natural products based on monitoring Bip/GRP78 promoter activity during cancer cell growth, at the level of the single cell, by a bioluminescence microscopy system that had several advantages compared with fluorescence imaging. It was found that several chemical chaperones, such as ferulic acid (FA), silybin, and rutin, affected the activity. We visualized EVs from cancer cells using bioluminescence imaging and showed that several EVs could be observed when using CD63 fused with NanoLuc luciferase, which has a much smaller molecular weight and higher intensity than conventional firefly luciferase.
affected the activity. We visualized EVs from cancer cells using bioluminescence imaging and showed that several EVs could be observed when using CD63 fused with NanoLuc luciferase, which has a much smaller molecular weight and higher intensity than conventional firefly luciferase.
We then examined the effects of the chemical chaperones on EVs from cancer cells by bioluminescence imaging and quantified the expression of CD63 in these EVs. It was found that the chemical chaperones examined in this study affected CD63 levels in EVs. These results showed that imaging at the level of the single cell using bioluminescence is a powerful tool and could be used to evaluate chemical chaperones and EVs from cancer cells. This approach may produce new information in this field when taken together with conventional and classical methods. 
| INTRODUCTION
A quality control system for newly synthesized cellular proteins is essential and indispensable for all prokaryotes and eukaryotes. [1] Molecular chaperones play significant roles in this system such as distinguishing between unfolded and folded newly synthesized proteins and assisting in their correct folding. Correct folding is an indispensable step in the intrinsic function of these proteins, especially in the regulation of protein homeostasis, including influencing cell expression levels when responding to environmental and physiological stresses such as heat shock or ER stress. [1] [2] [3] [4] Several low-molecular-weight compounds derived from natural products, such as ferulic acid (trans-4-hydroxy-3-methoxycinnamic acid; FA), sodium 4-phenylbutyrate (4PBA), γ-oryzanol, silybin, kojic acid (5-hydroxy-2-hydroxymethyl-4-pyrone),
and rutin (quercetin 3-rutinoside) are known to have chaperone-like activities, can function as chemical chaperones or antioxidants, and are able to regulate chaperone proteins or ER stress. [5] [6] [7] [8] [9] [10] [11] It is known that binding immunoglobulin protein, Bip (also known as GRP78) is a molecular chaperone protein mainly located in ER [4] and is often used as marker when examining ER stress, during which Bip/GRP78
is upregulated in cells. [5, 9] Thus, Bip/GRP78 is also used to examine the effect of chemical chaperones on ER stress in cells. [5, 9] Several of these chemical chaperones are currently expected to be used in the clinic, as 4PBA has been approved by the United States Food and Drug Administration (US FDA) for the treatment of urea cycle disorders. [7] Therefore, a method to evaluate the effects of these chemical chaperones would be useful not only for screening for new chemical chaperones but also for the development of new drugs, using these chemical chaperones as lead compounds.
Extracellular vesicles including exosomes have been widely investigated and are receiving increasing attention in studies on their basic function and content to their development as therapeutic or diagnostic tools for several diseases. [12] They consist of a lipid bilayer membrane and contain proteins, receptors, nucleic acid including microRNAs, chemicals, and structural contents derived from the original cell. [13] [14] [15] Extracellular vesicles are usually classified according to their size and biological specificity as exosomes (30-100 nm), [13] microvesicles (50-1000 nm) [15] and apoptotic bodies (500-2000 nm). [15] Exosomes are currently the most well studied type of EV and studies have mainly focussed on cancer cell biology, treatment and diagnosis. [12] In addition, it has been reported recently that the ER stress response could affect EV secretion or content. [16, 17] Therefore a method for the detection and real-time imaging of EVs, including exosomes, would be useful not only to investigate EV mechanisms but also to evaluate drugs that regulate EVs that are secreted from cancer cells.
Previously, we have monitored Bip/GRP78 promoter activity during cancer cell growth by real-time imaging at the level of the single cell using a bioluminescence microscopy system, in which a cooling charge coupled device (CCD) camera was successfully combined with a microscope as a new optical system. [18] Bioluminescence and morphology was detected and observed at the single cell level using this system, and was important in selecting live cells and excluding false positives. This technique is a suitable and available tool not only for gene analysis related to the regulation of unfolded protein responses in cancer cells but also for evaluation of anti-cancer agent efficacy. [18] The main advantages in using bioluminescence imaging from luciferin-luciferase reaction emissions are its lower background, and higher quantification. [19, 20] In addition there is low damage to living cells compared with the use of fluorescent proteins or fluorescein isothiocyanate, as an excitation light source is not needed for detection. [19, 20] Monitoring by real-time imaging using bioluminescence would therefore provide additional information when combined with conventional and classic assays.
It is known that ER stress and EVs play significant roles in cancer cells, [4, 12] exosomes, secreted from cancer cells were evaluated using bioluminescence emitted from NanoLuc, [21] the intensity of which was much higher than that of conventional firefly luciferase. CD63 levels in these EVs were quantified in the presence or absence of chemical chaperones. Two kinds of luciferases were observed simultaneously to evaluate imaging using a bioluminescence microscopy system. The human glioblastoma U251 cell line was obtained as reported previously. [22] U251 cells stably transfected with pBipPro-Luc (U251/ Luc), in which the promoter region of Bip was cloned into the pGL4.14 vector (Promega, Madison, WI, USA), were established previously. [18] The cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum (FBS) as reported previously. [22] Other reagents were mostly from Nacalai Tesque (Kyoto, Japan).
| Construction of reporter plasmid and expression vector, transfection, and establishment of stable cell lines
The pBipPro-Luc reporter plasmid was constructed as reported previously. [22] The CD63 expression vector fused with NanoLuc (Nacalai Tesque) as described previously.
[18]
| Imaging and time-course analysis using bioluminescence
Imaging using bioluminescence at the single cell level was performed using the bioluminescence microscopy system LUMINOVIEW (LV200)
Imaging System (Olympus, Tokyo, Japan) as reported previously. [22] Briefly, a culture dish was kept at 37°C during the observation, and images were obtained using a × 100 magnification objective lens after addition of D-luciferin (Promega) to the culture medium at the final concentration of 500 μM. The Nano-Glo Live Cell Assay System (Promega) was also used to detect NanoLuc during live imaging at the single cell level using the LV200 system. Here, the diluted Nano-Glo Complete resection is currently difficult, although therapeutic approaches such as surgical treatment and chemotherapy are improving. [23] It has been previously reported that Bip/Grp78 is a novel candidate target for improving chemosensitivity against malignant glioma, and Bip suppression in glioblastoma cells would be a novel approach to improve treatment. [24] We first evaluated the effects of several chemical chaperones on Bip promoter activity in glioblastoma cells by bioluminescence imaging at the single cell level. As shown in Figure 1 , the Bip promoter was activated during cancer cell growth, with activation peaks observed several times during long-term observation of cancer cell growth, as reported previously. [18] When we performed real-time monitoring of Bip promoter activity by bioluminescence imaging at the single cell level in the presence of FA, 4PBA, γ-oryzanol, silybin, kojic acid, or rutin, Bip promoter activity was affected and several patterns of promoter activity were observed with the chemical chaperones (Figure 1b) . Activation peaks for the promoter were not observed in the presence of FA or silybin, but were still found in the presence of 4PBA, γ-oryzanol, kojic acid, and rutin, although these peaks were lower than in those cells with no treatment (Figure 1b) . It is suggested that all these compounds could affect Bip promoter activation to varying degrees during cancer cell growth. FA, silybin, and rutin also caused sustained and gradual decrease of bioluminescence intensity during monitoring. When we examined cell viability in the presence of these chemical chaperones, no compound affected cell viability dramatically ( Figure S1a ). Thus it is suggested that this decrease in bioluminescence intensity was not caused by damage, such as by cell death or cytotoxicity, of these compounds when analysed together with imaging in these cells using the bioluminescence microscopy system, in which marked morphological abnormalities were not observed. When the reporter assay was performed in the presence of these chemical chaperones using a luminometer, FA, silybin, and kojic acid caused a decrease in fold activation of the Bip promoter, however this decrease was slight and a marked change in fold activation was not observed using the reporter assay ( Figure S1b ). The luminescence intensities of selected regions of interests (ROI) from bioluminescence images at 24 h after treatment with these chemical chaperones were also examined, and a similarity with the results from the reporter assay was observed ( Figure S1c ). The data obtained from the reporter assay using a luminometer represent the sum of the bioluminescence from all extracted cells in the dish or well on a plate and this method is an end-point assay.
If the remaining luciferase is still active in the cells after cells had died, 
| Imaging of EVs including exosomes using bioluminescence
We next visualized EVs including exosomes from cancer cells using bioluminescence imaging at the single cell level. Extracellular vesicles are currently widely investigated and receiving increasing attention in many research areas, but there are few established methods for imaging EVs using bioluminescence, although imaging using fluorescence such as with green fluorescent protein (GFP) is currently performed. [25] We constructed an expression vector containing CD63 fused with Nano Luc luciferase (CD63NLuc) (Figure S2a ), in which CD63 is a tetraspanin that is synthesized in the ER, and is required for biogenesis of a subpopulation of exosomes. CD63 is one of the most characterized marker proteins in exosomes, [13, 26, 27] and Nano
Luc is small luciferase (~19.1 kDa) derived from Oplophorus gracilirostris that can emit much higher bioluminescence intensities in the absence of ATP than firefly luciferase. [21] We therefore established a Real-time imaging could be conducted for at least for 30 min with sufficient bioluminescence intensity to observe EVs when captured every 3-5 sec exposure; the overall bioluminescence intensity emitted Many membranes, receptors, and secretory proteins are synthesized in the ER, [28] the ER stress response can affect ER secretion or contents [16, 17] and FA and rutin can affect and regulate ER stress. [5, 9] Therefore we investigated the effects of chemical chaperones on EV subtypes in cancer cell lines, in which the protein expression patterns and levels were distinct, have been reported previously. [29] We simultaneously observed both Nano Luc (EVs) and firefly Luc (fLuc) (Bip promoter activity). A CD63NLuc/BipfLuc/U251 stable cell line, in which pBipPro-fLuc was transfected into CD63NLuc/U251 cells, was successfully established. Simultaneous observation was performed using two kinds of filters and the LV200 system to discriminate the two types of bioluminescence (Nano Luc and fLuc), These bioluminescence intensities were lower than that of individual observations through the filters ( Figure S5a ). In time-lapse imaging of both Nano Luc and fLuc, the bioluminescence intensity of Nano Luc quickly decreased during the imaging (data not shown), therefore real-time monitoring of both Nano Luc and fLuc simultaneously was not performed. However, the intensities of both EVs (Nano Luc) and Bip promoter activity (fLuc) through ROIs selection after FA treatment decreased ( Figure S5b ). Simultaneous observation of two types of bioluminescence at the single cell level may be a new available method, although there are currently several limitations to its use. Use of the techniques and methods described here would produce additional information when taken together with conventional and classical methods.
| CONCLUSIONS
The data presented in this study describe imaging at the single cell level using bioluminescence and a new type of luciferase. Nano Luc can be used for the evaluation of chemical chaperones and also the visualization of cancer cell EVs and the EV protein expression levels.
Bioluminescence imaging through the simultaneous observation of Nano Luc and fLuc was demonstrated, although there were several limitations to the described current method. These bioluminescence imaging methods could be used in the future for further studies of not only for EVs including exosomes but also for screening, discovery, and development of new compounds for cancer treatment.
